Stay updated on Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.

Latest updates to the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedDifference0.0%

- Check15 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded Cordaleo, Turkey as a study site; removed Karşıyaka, Turkey as a study site.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a detailed description of the two-part study design (dose escalation and expansion) and clarified treatment arms, dosing schedules, and timelines. Updated the study's participating locations and expanded cohort information.SummaryDifference3%

- Check57 days agoChange DetectedAdded a prominent notice about a lapse in government funding, stating that information may not be up to date and inquiries may not be processed; included links to status pages. Revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.